Biblio

Export 11300 results:
Author Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
tau Proteins
J. Vallortigara, Whitfield, D., Quelch, W., Alghamdi, A., Howlett, D., Hortobágyi, T., Johnson, M., Attems, J., O'Brien, J. T., Thomas, A., Ballard, C. G., Aarsland, D., and Francis, P. T., Decreased Levels of VAMP2 and Monomeric Alpha-Synuclein Correlate with Duration of Dementia., J Alzheimers Dis, vol. 50, no. 1, pp. 101-10, 2016.
A. Malishkevich, Marshall, G. A., Schultz, A. P., Sperling, R. A., Aharon-Peretz, J., and Gozes, I., Blood-Borne Activity-Dependent Neuroprotective Protein (ADNP) is Correlated with Premorbid Intelligence, Clinical Stage, and Alzheimer's Disease Biomarkers., J Alzheimers Dis, vol. 50, no. 1, pp. 249-60, 2016.
E. Morenas-Rodriguez, Cervera-Carles, L., Vilaplana, E., Alcolea, D., Carmona-Iragui, M., Dols-Icardo, O., Ribosa-Nogué, R., Muñoz-Llahuna, L., Sala, I., M Sánchez-Saudinós, B., Blesa, R., Clarimón, J., Fortea, J., and Lleo, A., Progranulin Protein Levels in Cerebrospinal Fluid in Primary Neurodegenerative Dementias., J Alzheimers Dis, vol. 50, no. 2, pp. 539-46, 2016.
J. Bennett, Burns, J., Welch, P., and Bothwell, R., Safety and Tolerability of R(+) Pramipexole in Mild-to-Moderate Alzheimer's Disease., J Alzheimers Dis, vol. 49, no. 4, pp. 1179-87, 2016.
D. A. Nation, Ho, J., and Yew, B., Older Adults Taking AT1-Receptor Blockers Exhibit Reduced Cerebral Amyloid Retention., J Alzheimers Dis, vol. 50, no. 3, pp. 779-89, 2016.
H. Qiu, Zhong, R., Liu, H., Zhang, F., Li, S., and Le, W., Chronic Sleep Deprivation Exacerbates Learning-Memory Disability and Alzheimer's Disease-Like Pathologies in AβPP(swe)/PS1(ΔE9) Mice., J Alzheimers Dis, vol. 50, no. 3, pp. 669-85, 2016.
D. Renard, Wacongne, A., Ayrignac, X., Charif, M., Fourcade, G., Azakri, S., Le Floch, A., Bouly, S., Marelli, C., Arquizan, C., Hirtz, C., Gabelle, A., Thouvenot, E., and Lehmann, S., Cerebrospinal Fluid Alzheimer's Disease Biomarkers in Cerebral Amyloid Angiopathy-Related Inflammation., J Alzheimers Dis, vol. 50, no. 3, pp. 759-64, 2016.
G. Koch, Di Lorenzo, F., Del Olmo, M. Fernandez, Bonní, S., Ponzo, V., Caltagirone, C., Bozzali, M., and Martorana, A., Reversal of LTP-Like Cortical Plasticity in Alzheimer's Disease Patients with Tau-Related Faster Clinical Progression., J Alzheimers Dis, vol. 50, no. 2, pp. 605-16, 2016.
C. -cui Yang, Kuai, X. -xian, bin Gao, W. -, Yu, J. -chun, Wang, Q., Li, L., and Zhang, L., Morroniside-Induced PP2A Activation Antagonizes Tau Hyperphosphorylation in a Cellular Model of Neurodegeneration., J Alzheimers Dis, vol. 51, no. 1, pp. 33-44, 2016.
C. Huang, Ng, O. Tsz- Wa, Ho, Y. - S., Irwin, M. Garnet, Chang, R. Chuen- Chun, and Wong, G. Tin- Chun, Effect of Continuous Propofol Infusion in Rat on Tau Phosphorylation with or without Temperature Control., J Alzheimers Dis, vol. 51, no. 1, pp. 213-26, 2016.
H. - F. Wang, Tan, L., Cao, L., Zhu, X. - C., Jiang, T., Tan, M. - S., Liu, Y., Wang, C., Tsai, R. M., Jia, J. - P., and Yu, J. - T., Application of the IWG-2 Diagnostic Criteria for Alzheimer's Disease to the ADNI., J Alzheimers Dis, vol. 51, no. 1, pp. 227-36, 2016.
K. E. Melah, Lu, S. Yuan- Fu, Hoscheidt, S. M., Alexander, A. L., Adluru, N., Destiche, D. J., Carlsson, C. M., Zetterberg, H., Blennow, K., Okonkwo, O. C., Gleason, C. E., N Dowling, M., Bratzke, L. C., Rowley, H. A., Sager, M. A., Asthana, S., Johnson, S. C., and Bendlin, B. B., Cerebrospinal Fluid Markers of Alzheimer's Disease Pathology and Microglial Activation are Associated with Altered White Matter Microstructure in Asymptomatic Adults at Risk for Alzheimer's Disease., J Alzheimers Dis, vol. 50, no. 3, pp. 873-86, 2016.
M. Frenkel-Pinter, Tal, S., Scherzer-Attali, R., Abu-Hussien, M., Alyagor, I., Eisenbaum, T., Gazit, E., and Segal, D., Naphthoquinone-Tryptophan Hybrid Inhibits Aggregation of the Tau-Derived Peptide PHF6 and Reduces Neurotoxicity., J Alzheimers Dis, vol. 51, no. 1, pp. 165-78, 2016.
E. Niemantsverdriet, Goossens, J., Struyfs, H., Martin, J. - J., Goeman, J., De Deyn, P. Paul, Vanderstichele, H., and Engelborghs, S., Diagnostic Impact of Cerebrospinal Fluid Biomarker (Pre-)Analytical Variability in Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 1, pp. 97-106, 2016.
J. - P. Morin, Cerón-Solano, G., Velázquez-Campos, G., Pacheco-López, G., Bermúdez-Rattoni, F., and Díaz-Cintra, S., Spatial Memory Impairment is Associated with Intraneural Amyloid-β Immunoreactivity and Dysfunctional Arc Expression in the Hippocampal-CA3 Region of a Transgenic Mouse Model of Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 1, pp. 69-79, 2016.
X. - P. Hong, Chen, T., Yin, N. - N., Han, Y. - M., Yuan, F., Duan, Y. - J., Shen, F., Zhang, Y. - H., and Bin Chen, Z. -, Puerarin Ameliorates D-Galactose Induced Enhanced Hippocampal Neurogenesis and Tau Hyperphosphorylation in Rat Brain., J Alzheimers Dis, vol. 51, no. 2, pp. 605-17, 2016.
B. N. Dugger, Whiteside, C. M., Maarouf, C. L., Walker, D. G., Beach, T. G., Sue, L. I., Garcia, A., Dunckley, T., Meechoovet, B., Reiman, E. M., and Roher, A. E., The Presence of Select Tau Species in Human Peripheral Tissues and Their Relation to Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 2, pp. 345-56, 2016.
E. Aso, Andrés-Benito, P., Carmona, M., Maldonado, R., and Ferrer, I., Cannabinoid Receptor 2 Participates in Amyloid-β Processing in a Mouse Model of Alzheimer's Disease but Plays a Minor Role in the Therapeutic Properties of a Cannabis-Based Medicine., J Alzheimers Dis, vol. 51, no. 2, pp. 489-500, 2016.
R. A. Stern, Tripodis, Y., Baugh, C. M., Fritts, N. G., Martin, B. M., Chaisson, C., Cantu, R. C., Joyce, J. A., Shah, S., Ikezu, T., Zhang, J., Gercel-Taylor, C., and Taylor, D. D., Preliminary Study of Plasma Exosomal Tau as a Potential Biomarker for Chronic Traumatic Encephalopathy., J Alzheimers Dis, vol. 51, no. 4, pp. 1099-109, 2016.
M. T. White, Shaw, L. M., and Xie, S. X., Evaluation of Cerebrospinal Fluid Assay Variability in Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 2, pp. 463-70, 2016.
C. Hyoung Lyoo, Cho, H., Choi, J. Yong, Hwang, M. Song, Hong, S. Kyoon, Kim, Y. Joong, Ryu, Y. Hoon, and Lee, M. Sik, Tau Accumulation in Primary Motor Cortex of Variant Alzheimer's Disease with Spastic Paraparesis., J Alzheimers Dis, vol. 51, no. 3, pp. 671-5, 2016.
L. Grangeon, Paquet, C., Bombois, S., Quillard-Muraine, M., Martinaud, O., Bourre, B., Lefaucheur, R., Nicolas, G., Dumurgier, J., Gerardin, E., Jan, M., Laplanche, J. - L., Peoc'h, K., Hugon, J., Pasquier, F., Maltête, D., Hannequin, D., and Wallon, D., Differential Diagnosis of Dementia with High Levels of Cerebrospinal Fluid Tau Protein., J Alzheimers Dis, vol. 51, no. 3, pp. 905-13, 2016.
M. Elahi, Hasan, Z., Motoi, Y., Matsumoto, S. - E., Ishiguro, K., and Hattori, N., Region-Specific Vulnerability to Oxidative Stress, Neuroinflammation, and Tau Hyperphosphorylation in Experimental Diabetes Mellitus Mice., J Alzheimers Dis, vol. 51, no. 4, pp. 1209-24, 2016.
D. Andriuta, Moullart, V., Schraen, S., Devendeville, A., Meyer, M. - E., and Godefroy, O., What are the Most Frequently Impaired Markers of Neurodegeneration in ADNI Subjects?, J Alzheimers Dis, vol. 51, no. 3, pp. 793-800, 2016.
N. R. Barthélemy, Gabelle, A., Hirtz, C., Fenaille, F., Sergeant, N., Schraen-Maschke, S., Vialaret, J., Buée, L., Junot, C., Becher, F., and Lehmann, S., Differential Mass Spectrometry Profiles of Tau Protein in the Cerebrospinal Fluid of Patients with Alzheimer's Disease, Progressive Supranuclear Palsy, and Dementia with Lewy Bodies., J Alzheimers Dis, vol. 51, no. 4, pp. 1033-43, 2016.

Pages